{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:07:30Z","timestamp":1789092450547,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008493","name":"V\u00e4in\u00f6 and Laina Kivi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008469","name":"Filha","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006706","name":"Tampereen Tuberkuloosis\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008368","name":"Suomen Tuberkuloosin Vastustamisyhdistyksen S\u00e4\u00e4ti\u00f6 ry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008368","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartandlung.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart & Lung"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.hrtlng.2026.102789","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T19:41:07Z","timestamp":1776195667000},"page":"102789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Regular short-acting \u03b22-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring"],"prefix":"10.1016","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0215-0805","authenticated-orcid":false,"given":"Leon L.","family":"Csonka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iida","family":"V\u00e4h\u00e4talo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinja","family":"Ilmarinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leena E.","family":"Tuomisto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannu","family":"Kankaanranta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauri","family":"Lehtim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hrtlng.2026.102789_bib0001","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"390","author":"Vos","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0002","unstructured":"2024 GINA Main Report. Global initiative for asthma - GINA n.d. https:\/\/ginasthma.org\/2024-report\/(accessed May 28, 2024)."},{"key":"10.1016\/j.hrtlng.2026.102789_bib0003","unstructured":"Overview | Asthma: diagnosis, monitoring and chronic asthma management (BTS, NICE, SIGN) | Guidance | NICE 2024. https:\/\/www.nice.org.uk\/guidance\/NG245 (accessed May 4, 2025)."},{"key":"10.1016\/j.hrtlng.2026.102789_bib0004","unstructured":"Astma n.d. https:\/\/www.kaypahoito.fi\/hoi06030 (accessed May 28, 2024)."},{"key":"10.1016\/j.hrtlng.2026.102789_bib0005","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/0091-6749(85)90786-9","article-title":"Changes in bronchial hyperreactivity induced by 4 weeks of treatment with antiasthmatic drugs in patients with allergic asthma: a comparison between budesonide and terbutaline","volume":"76","author":"Kraan","year":"1985","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0006","first-page":"973","article-title":"Effects of long-term inhaled salbutamol therapy on the provocation of asthma by histamine","volume":"121","author":"Peel","year":"1980","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0007","doi-asserted-by":"crossref","first-page":"802","DOI":"10.7326\/0003-4819-140-10-200405180-00010","article-title":"Meta-analysis: respiratory tolerance to regular beta2-agonist use in patients with asthma","volume":"140","author":"Salpeter","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0008","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1056\/NEJM199210223271704","article-title":"Tolerance to the nonbronchodilator effects of inhaled beta 2-agonists in asthma","volume":"327","author":"O\u2019Connor","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2125.1995.tb04416.x","article-title":"Tolerance with beta 2-adrenoceptor agonists: time for reappraisal","volume":"39","author":"Grove","year":"1995","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0010","doi-asserted-by":"crossref","DOI":"10.1038\/npjpcrm.2015.42","article-title":"Sein\u00e4joki adult asthma study (SAAS): a protocol for a 12-year real-life follow-up study of new-onset asthma diagnosed at adult age and treated in primary and specialised care","volume":"25","author":"Kankaanranta","year":"2015","journal-title":"NPJ Prim Care Respir Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0011","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02383-2016","article-title":"Differences between asthma-COPD overlap syndrome and adult-onset asthma","volume":"49","author":"Tommola","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0012","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.rmed.2016.06.017","article-title":"A 12-year prognosis of adult-onset asthma: sein\u00e4joki Adult Asthma Study","volume":"117","author":"Tuomisto","year":"2016","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0013","unstructured":"Ohje astmapotilaan PEF-kotiseurantaan n.d. https:\/\/www.kaypahoito.fi\/nix01892 (accessed June 4, 2024)."},{"key":"10.1016\/j.hrtlng.2026.102789_bib0014","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/thx.47.3.162","article-title":"Validity of peak expiratory flow measurement in assessing reversibility of airflow obstruction","volume":"47","author":"Dekker","year":"1992","journal-title":"Thorax"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3132\/pcrj.2008.00064","article-title":"Use of peak expiratory flow for assessing bronchodilator responsiveness","volume":"18","author":"Aggarwal","year":"2009","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0016","doi-asserted-by":"crossref","DOI":"10.1080\/20018525.2025.2604396","article-title":"Relation of changes in PEF and FEV1 during bronchodilation in children","volume":"13","author":"Csonka","year":"2026","journal-title":"Eur Clin Respir J"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/pm\/7675935","article-title":"Relation of changes in PEF and FEV1 during salbutamol-induced bronchodilation after methacholine challenge test","volume":"2025","author":"Csonka","year":"2025","journal-title":"Pulm Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0018","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.rmed.2019.03.010","article-title":"Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone","volume":"151","author":"Kerwin","year":"2019","journal-title":"Respir Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0019","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1080\/02770903.2019.1709864","article-title":"Home self-monitoring in patients with asthma using a mobile spirometry system","volume":"58","author":"Kupczyk","year":"2021","journal-title":"J Asthma"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0020","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1002\/ppul.21183","article-title":"Is home spirometry useful in diagnosing asthma in children with nonspecific respiratory symptoms?","volume":"45","author":"Brouwer","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0021","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.chest.2023.06.029","article-title":"Clinic vs home spirometry for monitoring lung function in patients with asthma","volume":"164","author":"Oppenheimer","year":"2023","journal-title":"CHEST"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0022","doi-asserted-by":"crossref","DOI":"10.1111\/cpf.12898","article-title":"Relation of changes in peak expiratory flow (PEF) and forced expiratory volume in 1\u2009s (FEV1) during bronchoconstriction","author":"Csonka","year":"2024","journal-title":"Clin Physiol Funct Imaging"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0023","first-page":"150","article-title":"Reliability of peak expiratory flow measurement in assessing bronchodilator response of airflow obstruction","volume":"1","author":"Ozturk","year":"2010","journal-title":"J Asthma Allergy Educ"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0024","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/S0031-3955(16)38443-7","article-title":"Pediatric pulmonary function testing in asthma","volume":"39","author":"Mueller","year":"1992","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0025","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-3003.1999.14a07.x","article-title":"The effect of patient technique and training on the accuracy of self-recorded peak expiratory flow","volume":"14","author":"Gannon","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0026","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12890-019-0837-3","article-title":"Comparison of bench test results measuring the accuracy of peak flow meters","volume":"19","author":"VanZeller","year":"2019","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0027","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3233\/THC-220122","article-title":"Performance testing for different peak expiratory flow meters","volume":"31","author":"Wu","year":"2023","journal-title":"Technol Health Care"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0028","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.jaci.2008.07.040","article-title":"Steroids completely reverse albuterol-induced beta(2)-adrenergic receptor tolerance in human small airways","volume":"122","author":"Cooper","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.hrtlng.2026.102789_bib0029","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/j.jaci.2010.02.007","article-title":"Mechanism of glucocorticoid protection of airway smooth muscle from proasthmatic effects of long-acting beta2-adrenoceptor agonist exposure","volume":"125","author":"Nino","year":"2010","journal-title":"J Allergy Clin Immunol"}],"container-title":["Heart & Lung"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326000737?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0147956326000737?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T01:53:27Z","timestamp":1789091607000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0147956326000737"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":29,"alternative-id":["S0147956326000737"],"URL":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102789","relation":{},"ISSN":["0147-9563"],"issn-type":[{"value":"0147-9563","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regular short-acting \u03b22-agonist use over two weeks does not increase diurnal variation or induce tolerance during home PEF monitoring","name":"articletitle","label":"Article Title"},{"value":"Heart & Lung","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hrtlng.2026.102789","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102789"}}